The Gift of Sober Driving
Impact on your practice
This is a public awareness campaign with minimal direct impact on therapist practice. Therapists treating substance use disorders may reference the campaign with clients, but no billing, licensure, or policy changes are indicated.
Key facts
SAMHSA National Impaired Driving Prevention Month observance
Highlights substance use and traffic safety connection
References historical public policy successes in reducing alcohol-related fatalities
Awareness campaign with no specific new policy or funding changes
Therapy Companion analysis
This awareness campaign carries minimal direct operational impact on your practice, but it does create an important clinical documentation and risk management opportunity. If you treat patients with substance use disorders, opioid use disorder, or co-occurring mental health and substance use conditions, you should integrate impaired driving risk assessment into your clinical intake and ongoing treatment planning. The campaign reinforces that prescription medications—including those you may be documenting in patient charts—carry driving impairment warnings equivalent to controlled substances. This means when you prescribe or coordinate care with prescribers using benzodiazepines, opioids, or sedating antidepressants, your clinical notes should document that you discussed driving safety and the patient's understanding of medication-related impairment risks. From a liability perspective, if a patient on your caseload causes a traffic fatality while impaired, your documentation of whether you addressed this risk becomes discoverable. Your billing and treatment planning should reflect substance use and driving safety as integrated clinical concerns, not separate issues. For therapists in states with mandatory reporting laws or duty-to-warn statutes, knowing a patient plans to drive while impaired may trigger reporting obligations—document your clinical reasoning clearly. This is particularly relevant if you work in opioid treatment programs, intensive outpatient programs for substance use, or community mental health centers serving high-risk populations.
Background
SAMHSA's December 2022 campaign reflects ongoing federal concern about preventable traffic deaths linked to substance use. The data is stark: approximately 32 Americans die daily in alcohol-impaired crashes, and 56 percent of seriously injured or killed drivers tested positive for at least one drug. While alcohol-related fatalities have declined since the 1980s due to policy interventions and public awareness, drug-impaired driving remains a persistent public health crisis. This campaign is part of a broader federal strategy to normalize conversations about impaired driving risk across healthcare, education, and community settings. For therapists, this signals that substance use treatment and mental health care are increasingly expected to address traffic safety as a core outcome measure, not an ancillary concern. The emphasis on prescription and over-the-counter medications—not just illicit drugs—means your clinical documentation practices around medication counseling are now part of the national impaired driving prevention infrastructure.
What you should do
Integrate a standardized impaired driving risk assessment into your substance use disorder intake form and annual treatment plan reviews. Document whether you discussed driving safety, medication-related impairment risks, and the patient's commitment to sober driving. This protects you legally and demonstrates clinical competence.
When coordinating care with prescribers or reviewing medication lists, flag any medications with 'do not operate heavy machinery' warnings in your clinical notes and document that you counseled the patient on driving restrictions. Include this in your treatment planning if the patient reports active driving.
For patients in opioid treatment programs or intensive outpatient substance use treatment, add driving safety and transportation planning to your discharge planning checklist. Document whether the patient has reliable sober transportation and whether they understand the legal and clinical risks of driving while impaired.
Review your agency's policies on mandatory reporting and duty-to-warn statutes. If a patient discloses plans to drive while impaired or you have clinical concern about imminent risk, document your clinical reasoning for any reporting or intervention you undertake. Consult your supervisor or legal counsel if unclear.
Use SAMHSA's National Helpline (800-662-4357) and 988 Suicide & Crisis Lifeline as referral resources in your clinical materials and patient handouts. These are free, confidential resources that complement your practice and can be referenced in your treatment planning documentation.
Notable excerpts
About 30 percent of all traffic fatalities in the United States involve a driver who is alcohol impaired. Each day, about 32 people in the United States die in a crash in which at least one driver is alcohol impaired. That's one person every 45 minutes. (SAMHSA, December 2022)
Some prescription and over-the-counter medications can cause extreme drowsiness, dizziness, and other side effects. If there's a warning on the medication about 'operating heavy machinery,' that includes driving a vehicle. (SAMHSA, December 2022)
It's illegal everywhere in the United States to drive under the influence of alcohol, marijuana, opioids, methamphetamines, or any potentially impairing drug. This includes prescribed and over-the-counter medications. (SAMHSA, December 2022)
View full source text
Original source
https://www.samhsa.gov/blog/gift-sober-drivingPolicy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
[MA] H4895: Expanding access to mental health services
This bill aims to expand mental health service access in Massachusetts and has cleared committee with a favorable recommendation. Depending on final language, it could affect reimbursement rates, telehealth authorization, or insurance coverage requirements.
[TN] SB1248: AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
This comprehensive TN mental health bill touches multiple code sections and could affect licensure, scope of practice, insurance requirements, and workforce regulations. Therapists should monitor its progress closely as it moves through committee.
Advancing the Future of Behavioral Health Data Exchange
This policy direction addresses a critical pain point for therapists: the lack of integrated health data exchange with primary care and medical providers. Improved interoperability could reduce documentation burden, improve care coordination, and reduce liability from medication interactions or missed diagnoses. However, it may also increase compliance requirements and data security obligations.
Opinion: MAHA is rewriting the vocabulary of American mental health care
Federal deprescribing initiatives create new clinical and billing opportunities for therapists while potentially pressuring prescribing practices. Therapists should understand the evidence, reimbursement rules, and ethical considerations around medication tapering to protect clients and navigate changing clinical norms.